Health Canada has released a new Draft Good Manufacturing Practices (GMP) Guide for Natural Health Products (NHPs), marking a significant update in the regulation of supplements, herbal remedies, vitamins, and other natural health products in Canada. If you’re a manufacturer, distributor, or consumer of NHPs, this draft guide is worth paying attention to—it could shape
The biopharmaceutical industry operates within a complex web of regulatory requirements, demanding meticulous attention to quality and compliance at every stage of a project. From early-stage research to commercial manufacturing, deviations can have significant consequences, impacting patient safety, product efficacy, and the company’s reputation. Optimizing quality and compliance is not merely about ticking boxes; it’s a strategic imperative that drives efficiency, reduces risks, and fosters innovation.
In today’s rapidly evolving biotechnology landscape, regulatory challenges often determine the difference between groundbreaking innovations that reach patients and those that remain trapped in development limbo. We’re excited to announce the release of our comprehensive white paper, “Navigating the Regulatory Landscape: 10 Critical Challenges for Biotech Companies,” designed to help innovators chart a successful course
Understanding and navigating the complexities of these frameworks is essential for organizations seeking efficiency, innovation, and regulatory alignment.
Artificial Intelligence (AI) has rapidly emerged as a transformative technology, revolutionizing industries across the globe. One area where AI is making significant strides is in Quality Management Systems (QMS). By leveraging AI-powered solutions, organizations can enhance efficiency, improve decision-making, and achieve higher levels of quality. In this article, we will explore the various ways AI
